Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Employer - Self Funded Plans
View:
Post by LithLover on Dec 02, 2022 2:51pm

Employer - Self Funded Plans

LinkedIn a few hours ago:
StageZero Life Sciences Ltd. (TSX: SZLS)

It’s well known that cancer survival rates improve with early detection. But did you know that treating late-stage cancer is almost double the cost of treating early-stage cancer? If you’re an employer looking to mitigate the high cost of catastrophic cancer claims to your self-funded plan, contact us to learn more about our cancer prevention and early detection programs.

Learn more at https://lnkd.in/eyk7Hc6W


https://www.stagezerolifesciences.com/employers.html
Comment by molotov420 on Dec 02, 2022 4:37pm
they should really spend more on marketing...last quarter seems like a record low of $51K spent compared to $228K in 2021. In the MD&A they say in 2022 they "Expanded marketing programs" and in the next 12 months they will be focusing on "Driving revenue growth by significantly increasing spend against promotion". That is the first item on the list!!! Can't say I'm ...more  
Comment by Liked2Think on Dec 02, 2022 5:42pm
Companies selling a new backpack have a better marketing plan than this outfit. I mean we should be seeing ads everywhere on facebook and other places that cost a pathetic small amount to do yet we see nothing. They could pay a co op student to do it. Just another example of the joke that is StageHeadingToZero. 18 months after buying a company that made $1M a quarter this outfit can only muster ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities